Human Vaccines & Immunotherapeutics We welcome your submissions

Human Vaccines & Immunotherapeutics

Human Vaccines & Immunotherapeutics is an international peer-reviewed journal with a 2016 impact factor of 2.157. ​Human Vaccines & Immunotherapeutics is indexed in PubMed/Medline, Scopus, and more. The journal publishes original research papers, reviews, commentaries, case reports and meeting reports, as well as Special Focus sections featuring a group of articles on a broad topic of general interest, on all aspects of human vaccinology and immunotherapy, including:

- research and development of novel vaccines and
- experimental vaccines and novel approaches in vaccination and
- vaccines and immunotherapeutics for treatment of non-infectious
                                                            diseases, e.g., cancer, allergies
                                                          - licensed products: use, improvements, programs, safety,
                                                            perceptions, and regulation
                                                          - prevention and treatment in the developing world
                                                          - epidemiology and pharmaco-economics

Human Vaccines & Immunotherapeutics has an outstanding Editorial Board and offers a rapid and efficient peer-review process as well as a flexible open access (OA) policy. Authors can purchase immediate OA for a reasonable fee. Twelve months after publication, all published papers are available for Free Access.

Beyond the prestige of publishing in this renowned journal, other benefits include:

- a robust peer review process
​- ability to share your research with 50 free e-prints and tips on promoting your article via blogs and
  social media courtesy of our Author Resources site
- immediately see the impact your research made in the community: track downloads, citations, and
  the Altmetric Score of your article on My Authored Works

Submission Instructions

We invite you to submit your manuscript online at

Human Vaccines & Immunotherapeutics utilizes an online submission and tracking system designed to provide an efficient service to authors.

Presubmission inquiries regarding manuscripts that have been declined by other journals can be sent to Dr. Ronald Ellis, Editor-in-Chief at accompanied by the manuscript and decision letters/reviewers’ reports.  If deemed appropriate for HV&I, such manuscripts will enter our regular peer review process.

For complete submission instruction, visit our 'Instructions for Authors' page.

Editorial information